BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34226517)

  • 1. Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936.
    Hamilton OKL; Cox SR; Okely JA; Conte F; Ballerini L; Bastin ME; Corley J; Taylor AM; Page D; Gow AJ; Muñoz Maniega S; Redmond P; Valdés-Hernández MDC; Wardlaw JM; Deary IJ
    Transl Psychiatry; 2021 Jul; 11(1):376. PubMed ID: 34226517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between total MRI-visible small vessel disease burden and domain-specific cognitive abilities in a community-dwelling older-age cohort.
    Hamilton O; Cox SR; Ballerini L; Bastin ME; Corley J; Gow AJ; Muñoz Maniega S; Redmond P; Valdés Hernández MDC; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2021 Sep; 105():25-34. PubMed ID: 34022536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Charlton RA; Barrick TR
    Neuroimage Clin; 2017; 16():330-342. PubMed ID: 28861335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between total cerebral small vessel disease score and cognitive function in patients with vascular risk factors.
    Hosoya M; Toi S; Seki M; Saito M; Hoshino T; Yoshizawa H; Kitagawa K
    Hypertens Res; 2023 May; 46(5):1326-1334. PubMed ID: 36894746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
    Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
    Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
    Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
    J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.
    Kan CN; Gyanwali B; Hilal S; Ng KP; Venketasubramanian N; Chen CL; Xu X
    J Alzheimers Dis; 2020; 73(3):1053-1062. PubMed ID: 31884482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
    Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cumulative effect of small vessel disease lesions is reflected in structural brain networks of memory clinic patients.
    Heinen R; Vlegels N; de Bresser J; Leemans A; Biessels GJ; Reijmer YD;
    Neuroimage Clin; 2018; 19():963-969. PubMed ID: 30003033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke.
    Zhi N; Zhang L; Wang Y; Bai S; Geng J; Yu L; Cao W; Zhuang L; Zhou Y; Guan Y
    Aging (Albany NY); 2021 Feb; 13(7):9510-9521. PubMed ID: 33535189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life.
    Jansen MG; Griffanti L; Mackay CE; Anatürk M; Melazzini L; Lange AG; Filippini N; Zsoldos E; Wiegertjes K; Leeuw FE; Singh-Manoux A; Kivimäki M; Ebmeier KP; Suri S
    J Cereb Blood Flow Metab; 2022 Apr; 42(4):600-612. PubMed ID: 34610763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.
    Baykara E; Gesierich B; Adam R; Tuladhar AM; Biesbroek JM; Koek HL; Ropele S; Jouvent E; ; Chabriat H; Ertl-Wagner B; Ewers M; Schmidt R; de Leeuw FE; Biessels GJ; Dichgans M; Duering M
    Ann Neurol; 2016 Oct; 80(4):581-92. PubMed ID: 27518166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes in rich club organization and cognition in cerebral small vessel disease.
    van Leijsen EMC; van Uden IWM; Bergkamp MI; van der Holst HM; Norris DG; Claassen JAHR; Kessels RPC; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2019; 24():102048. PubMed ID: 31706220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Declining Physical and Cognitive Functions in the Lothian Birth Cohort 1936.
    Okely JA; Deary IJ
    J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1393-1402. PubMed ID: 31957799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes.
    Lesman-Segev OH; Golan Shekhtman S; Springer RR; Livny A; Lin HM; Yuxia O; Zadok M; Ganmore I; Heymann A; Hoffmann C; Domachevsky L; Schnaider Beeri M
    Sci Rep; 2024 Feb; 14(1):2741. PubMed ID: 38302529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural network changes in cerebral small vessel disease.
    Tuladhar AM; Tay J; van Leijsen E; Lawrence AJ; van Uden IWM; Bergkamp M; van der Holst E; Kessels RPC; Norris D; Markus HS; De Leeuw FE
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):196-203. PubMed ID: 31744851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.
    Ding J; Sigurðsson S; Jónsson PV; Eiriksdottir G; Charidimou A; Lopez OL; van Buchem MA; Guðnason V; Launer LJ
    JAMA Neurol; 2017 Sep; 74(9):1105-1112. PubMed ID: 28715552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Covariance Networks and Their Association with Age, Features of Cerebral Small-Vessel Disease, and Cognitive Functioning in Older Persons.
    Foster-Dingley JC; Hafkemeijer A; van den Berg-Huysmans AA; Moonen JE; de Ruijter W; de Craen AJ; van der Mast RC; Rombouts SA; van der Grond J
    Brain Connect; 2016 Nov; 6(9):681-690. PubMed ID: 27506114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Small Vessel Disease Burden Is Associated With Accelerated Poststroke Cognitive Decline: A 1-Year Follow-Up Study.
    Liang Y; Chen YK; Liu YL; Mok VCT; Ungvari GS; Chu WCW; Seo SW; Tang WK
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):336-343. PubMed ID: 31480986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.